ClinicalTrials.Veeva

Menu

Continuous Non-invasive Hemodynamic Monitoring in Early-onset Severe Preeclampsia: a Comparison of Echocardiography, Bioreactance, and Finger Cuff Measurements

Yale University logo

Yale University

Status

Completed

Conditions

Pre-Eclampsia

Treatments

Diagnostic Test: Echocardiogrpahy and non-invasive monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT05299229
2000028142

Details and patient eligibility

About

The purpose of this study is to compare the feasibility and accuracy of two methods of non-invasive hemodynamic assessments - bioreactance as assessed by non-invasive cardiac output monitoring (NICOM; Cheetah Medical) and pulse wave analysis as assessed by finger cuff arterial pressure (ClearSite, Edwards Life Sciences) - compared to hemodynamic assessments by intermittent echocardiography in early onset preeclampsia.

Enrollment

12 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BP >160 or DBP >110
  • gestational age between 20-34 weeks
  • singleton pregnancy

Exclusion criteria

  • prior diagnosis of chronic hypertension or hypertensive disorder of pregnancy
  • multi-fetal pregnancy

Trial design

12 participants in 1 patient group

Heart and vascular function
Description:
All study participants will have echocardiography and non-invasive monitoring by chest/back sensors and a finger cuff to determine the best method of monitoring heart and vascular function in preeclampsia.
Treatment:
Diagnostic Test: Echocardiogrpahy and non-invasive monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems